Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Timing of antibiotic therapy in the ICU

MH Kollef, AF Shorr, M Bassetti, JF Timsit, ST Micek… - Critical Care, 2021 - Springer
Severe or life threatening infections are common among patients in the intensive care unit
(ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial …

Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

Management strategies for severe Pseudomonas aeruginosa infections

H Do Rego, JF Timsit - Current Opinion in Infectious Diseases, 2023 - journals.lww.com
Carbapenem resistance in difficult-to-treat P. aeruginosa (DTR-PA) strains is primarily
mediated by loss or reduction of the OprD porin, overexpression of the cephalosporinase …

A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients

AJ Heffernan, SMS Lim, J Lipman… - Anaesthesia Critical Care & …, 2021 - Elsevier
Critically ill patients admitted to intensive care unit (ICU) with severe infections, or those who
develop nosocomial infections, have poor outcomes with substantial morbidity and mortality …

Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective …

A Vena, M Schenone, S Corcione… - Journal of …, 2024 - academic.oup.com
Objectives To determine the association of adequate empirical combination therapy (AECT)
with 30-day all-cause mortality in patients with septic shock due to Pseudomonas …

Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram …

F Barbier, C Dupuis, N Buetti, C Schwebel, É Azoulay… - Critical Care, 2024 - Springer
Key messages In this study including 391 critically ill patients with nosocomial pneumonia
due to Gram-negative pathogens, combination therapy was not associated with a reduced …

Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: A meta-analysis

L Onorato, M Macera, F Calò, P Cirillo… - International Journal of …, 2022 - Elsevier
Objectives To compare the clinical and microbiological outcomes of patients treated with
beta-lactam monotherapy or combination therapy for Pseudomonas aeruginosa infections …

Evaluating mono-and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model

ML Avent, KL McCarthy, FB Sime, S Naicker… - Microbiology …, 2022 - Am Soc Microbiol
Debate continues as to the role of combination antibiotic therapy for the management of
Pseudomonas aeruginosa infections. We studied the extent of bacterial killing by and the …

β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis

AJ Heffernan, FB Sime, J Sun, J Lipman… - International journal of …, 2020 - Elsevier
Background Combining aminoglycosides with β-lactam antibiotics for treating serious
infections has not been associated with reduced mortality in previous meta-analyses …